The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.95
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.10 (10.526%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment and Strategic Update

15 Mar 2022 07:00

RNS Number : 7374E
Microsaic Systems plc
15 March 2022
 

15 March 2022

 

 

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Board Appointment and Strategic Update

 

Microsaic (AIM: MSYS) is pleased to announce the appointment of Robert Moore as an independent Non-executive Director of the Company, with immediate effect.

 

Bob Moore is a UK qualified lawyer and brings over 35 years' commercial and legal experience to the Board. Bob has acted as Head of International Legal Affairs at Enterprise Oil plc (a UK FTSE 100 company prior to its acquisition by Shell in 2002) and as co-founder and Commercial Director of Granby Oil & Gas plc, which was listed on AIM from 2005 until its sale in 2008. Bob subsequently co-founded, and is Managing Director of, private oil and gas exploration company Ardent Oil Ltd (operating in the UK, Denmark and Luxembourg). Bob also acts as Non-executive Chairman of Mobile Streams plc, an AIM listed company, having been appointed to the role in July 2021.

 

Bob Moore will also join the Finance & Audit and Remuneration Committees of the board of directors of the Company.

 

Further to the announcement on 28 January that Glenn Tracey would be stepping down from his role as Chief Executive Officer ("CEO") to pursue a non-competitive opportunity, it has been agreed that he will leave on 31 March, rather than with effect from the date of the Company's next Annual General Meeting ("AGM") as previously announced.

 

The Company has begun a process to identify and appoint a successor CEO and from 1 April until that time, Gerry Brandon will temporarily serve as Executive Chairman of the Company. The Board is also making good progress with regard to the recruitment process for an additional independent non-executive director.

 

Gerard Brandon, Chairman of Microsaic, commented: "I'd like to thank Glenn again for his contribution over the past seven years and wish him every success in his new role.

 

"The Company is making progress in transforming from a proprietary equipment-only sales model, to a partner-based business model that adds contract micro-engineering design, build and commission of client equipment as a new revenue source. In addition, medical, environmental and bio-processing test services are to be carried out on Microsaic's own mass spectrometry equipment for external clients and are also expected to generate recurring revenue streams. As we seek to grow the Company through a combination of organic growth, joint ventures and the potential for future acquisitions, Bob is a welcome addition to the Board with his international commercial and legal experience."

 

Additional Disclosures Required under the AIM Rules for Companies 

In accordance with Schedule 2(g) of the AIM Rules for Companies, Robert ("Bob") Dennis Moore (aged 64) is, or has been within the previous five years, a director or partner of the following companies or partnerships:

 

Current directorships/partnerships

Past directorships/partnerships

 

Swiftpipe Ltd

Ardent Oil Ltd

Horizon Energy Partners Ltd

Horizon Energy Acquisition Ltd

Ardent Castings Ltd

Ardent Oil (Luxembourg) Holding SA

Ardent Oil (UK) SA

Mobile Streams plc

 

Cathay Oil and Gas Production Ltd

Petro River UK Limited

Ardent Oil Resources Limited

 

 

Bob Moore does not hold any ordinary shares in the Company.

 

Save as set out above, there is no further information to be disclosed in respect of Robert Moore under Schedule 2(g) of the AIM Rules.

 

 

Enquiries:

Microsaic Systems plc

Gerry Brandon Chairman

 

+44 (0)734 0055 648

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic

Microsaic develops and commercialises micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow, or in frontline environmental monitoring

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZLFFLXLFBBK
Date   Source Headline
5th Mar 20197:00 amRNSInvestor Event
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.